Skip to main content
AHCOAdaptHealth Corp.Sell5.3·$9.87-1.65%
AHCO · Why this verdict

Why AdaptHealth (AHCO) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score5.3/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

A deeply discounted valuation and rising volume accumulation contrast sharply with a pattern of persistent earnings misses and business quality metrics well below the minimum acceptable threshold, making the setup speculative and uninvestable despite the favorable headline risk/reward geometry.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Business quality at 1.9 out of 10 is well below the 4.0 minimum floor, with near-zero net margin, near-zero return on equity, thin gross margin, and no identifiable competitive moat — a combination that raises serious questions about long-run earnings sustainability.

Stable
Warnings
Expectation
Quality metrics improve above the 4.0 floor over the next 4 quarters, with return on equity turning meaningfully positive and gross margin expanding materially from current levels.

CounterCurrent depressed quality metrics may reflect a transitional period rather than a permanent structural condition; if margins recover from a cyclically depressed base, the quality floor can be cleared relatively quickly.

A forward price-to-earnings ratio of 8.5x and a PEG ratio of 0.03 place the stock at a deep discount to its stated earnings and growth profile, suggesting the market has priced in a highly pessimistic scenario.

Stable
Valuation breakdown
Expectation
Forward P/E remains below 12x while analyst price targets hold or rise over the next 12 months, preserving the discount even as estimates stabilize.

CounterAn extremely low PEG and P/E can reflect genuine structural deterioration in earnings power that makes current consensus estimates unreliable; if earnings are revised down materially, the apparent cheapness may be illusory.

The company has missed earnings estimates in three of the four most recent quarters — including a severe miss of approximately -530% most recently, followed by a -21% miss — with zero beats in the period, indicating persistent and worsening execution risk.

Stable
Earnings
Expectation
EPS beats consensus estimates in at least 2 of the next 4 quarters with a positive average surprise, signaling the miss pattern has broken.

CounterThe one in-line quarter in the period shows the company can at least meet sufficiently lowered expectations; if guidance is reset to a conservatively low bar, subsequent quarters could stabilize or produce modest beats from that reset base.

On-balance volume is rising (consistent with accumulation), and the 200-day moving average is still trending upward at approximately +1.8% per month — suggesting the current price weakness may be a pullback within a longer-term uptrend rather than confirmed structural breakdown.

Stable
Momentum breakdown
Expectation
Price reclaims the 200-day moving average within 60 days while on-balance volume continues to rise, confirming the pullback-in-uptrend characterization holds.

CounterRising on-balance volume and a still-ascending long-term average are necessary but not sufficient signals; if earnings continue to miss and quality metrics do not improve, accumulation by some buyers may prove insufficient to prevent further price deterioration.

Per-dimension breakdown

Value

9.1/10data confidence 83%
ComponentSub-score
P/S10.0
EV/EBITDA8.4
Fwd P/E9.5
PEG10.0
Analyst target7.5
  • Forward P/E: 8.5x
  • PEG: 0.03
  • Attractively valued

Quality

1.9/10data confidence 100%
ComponentSub-score
ROE0.0
ROA1.8
Gross margin0.1
Op margin0.3
Net margin0.0
Current ratio3.7
Moat3.6
Piotroski F5.6
  • No competitive moat
  • Quality concerns

Growth

6.9/10data confidence 67%
ComponentSub-score
Rev growth3.8
EPS growth10.0

Momentum

4.8/10data confidence 100%
ComponentSub-score
RSI4.5
MACD7.4
OBV10.0
MA position2.2
Volume0.0
  • Volume accumulation (rising OBV)
  • Below 200-MA but MA still rising (+1.1%/30d) — pullback in uptrend, not confirmed weakness

Sentiment

6.4/10data confidence 100%
ComponentSub-score
Analyst rating5.0
Price target9.3
erm sentiment5.0
  • Analyst upside: 42%

Insider

5.0/10data confidence 50%
ComponentSub-score
materiality5.0
holder change5.0
  • Insider selling (low materiality) — $113,426 (0.008% of mkt cap)

Peer rank

3.9/10data confidence 80%
ComponentSub-score
value rank9.5
quality rank2.7
growth rank3.3

Technical

5.2/10data confidence 100%
ComponentSub-score
bollinger5.2
support resistance5.8
52w position4.7

Risk (lower is worse)

3.9/10data confidence 100%
ComponentSub-score
short interest6.3
days to cover5.5
volatility4.0
put call0.0
implied vol2.1
beta5.1
debt equity4.4
  • Elevated put/call: 5.00
  • High IV: 68%

Catalyst

2.5/10data confidence 100%
ComponentSub-score
erm5.0
earnings history0.0
earnings timing5.0
surprise avg0.0
  • Earnings concerns: 0B/3M

How the verdict was assembled

Engine trigger

Quality below minimum threshold.

Engine technical detail
verdict_path: L1:HARD_BLOCK
Passed (8)
  • MOMENTUM:4.8>=4.5
  • ASYMMETRY:3.4>=1.5
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:39d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)

none

Warning (1)
  • MOMENTUM:4.8<5.5 (soft — BUY_NOW allowed but watch)
Reward-to-Risk
3.43
Upside
+23.5%
Downside
6.8%
Sizing output
AVOID

SetupRANGE_BOUND RSI 53 mid-range, Bollinger mid-band

EdgeNO_EDGE No clear edge identified

SuitabilityAGGRESSIVE Beta 1.46>1.3, MCap $1.4B<$5B

Investment implication

The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Value at 9.1 could not lift the engine output above the verdict floor.

The strongest dimensions are Value at 9.1, Growth at 6.9, and Sentiment at 6.4; the weakest are Quality at 1.9, Catalyst at 2.5, and Risk (lower is worse) at 3.9. The V9 engine cleared all gates with 1 warning, producing an asymmetric reward-to-risk of 3.43 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1A forward price-to-earnings ratio of 8.5x and a PEG ratio of 0.03 place the stock at a deep discount to its stated earnings and growth profile, suggesting the market has priced in a highly pessimistic scenario.

    Trip ifForward P/E expands above 15x while consensus EPS estimates for the next fiscal year are revised down by more than 20%.

  • P2The company has missed earnings estimates in three of the four most recent quarters — including a severe miss of approximately -530% most recently, followed by a -21% miss — with zero beats in the period, indicating persistent and worsening execution risk.

    Trip ifEPS beats consensus in at least 2 of the next 4 consecutive quarters with a positive average surprise.

  • P3Business quality at 1.9 out of 10 is well below the 4.0 minimum floor, with near-zero net margin, near-zero return on equity, thin gross margin, and no identifiable competitive moat — a combination that raises serious questions about long-run earnings sustainability.

    Trip ifOverall quality score rises above 4.0 for 2 consecutive quarterly assessments.

  • P4On-balance volume is rising (consistent with accumulation), and the 200-day moving average is still trending upward at approximately +1.8% per month — suggesting the current price weakness may be a pullback within a longer-term uptrend rather than confirmed structural breakdown.

    Trip ifPrice falls more than 15% below the 200-day moving average for more than 30 consecutive trading days.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks AHCO Why this verdict